Medistim

Regulatory Filings • Jan 3, 2020

From 2020, Medistim will report and send stock exchange announcements in English language only

From 2020, Medistim will report and send stock exchange announcements in English language only

(Oslo, January 3rd, 2020) Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarter in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces that the company from now on will inform the market in English.

Medistim has submitted an application to the Oslo Stock Exchange and Skatteetaten (The Norwegian Tax Administration) with a request to obtain an exemption to send stock exchange notices, as well as to prepare annual reports in English language only. Since the company's operations are internationally oriented, the working language and the industry language is English. In addition, the company communicates with investors and other key players mainly in English. On this basis, Medistim is granted an exemption to report and inform the market in English language only, and all information from Medistim will from now on be in English.

About Medistim:

Medistim was established in 1984, and has a track record of profitable growth over the past >15 years. The company is a pioneer within its segment, and continues to invest in new product development. Medistim has wholly owned subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark and Norway, in addition to the about 50 distributors in Europe, Asia, Middle East, Africa, Canada and South America. For more information, visit the Medistim home page: www.Medistim.com

This information is disclosed under Norwegian law (Verdipapirhandelloven §5-12).

For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA

Tel: + 47 918 38 110

Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA

Tel: + 47 906 59 940

Email: thomas.jakobsen@medistim.com